Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

15
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
15
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.0K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.0K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.1K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Contact between neighbourhood residents and residents of a residential care facility].

Tijdschrift voor psychiatrie·2018
Same author

[Intensive home treatment: a first observational evaluation].

Tijdschrift voor psychiatrie·2017
Same author

Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies.

Translational psychiatry·2017
Same author

[Medication review in the mental health care service: experiences on long-stay units].

Tijdschrift voor psychiatrie·2016
Same author

Quetiapine in relapsing schizophrenia: clinical efficacy and effect on monoaminergic parameters.

Acta neuropsychiatrica·2016
Same author

Pteridines and affective disorders.

Acta neuropsychiatrica·2016
Same journal

Serum Levels of IFN-γ and NGF as Potential Biomarkers of Depressive Disorders.

Acta neuropsychiatrica·2026
Same journal

The Danish Region Midt Schizophrenia Cohort - Representative, long-term follow-up of first-episode schizophrenia spectrum disorder.

Acta neuropsychiatrica·2026
Same journal

The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review.

Acta neuropsychiatrica·2026
Same journal

Breaking down the ADHD construct to build a valid diagnosis.

Acta neuropsychiatrica·2026
Same journal

A comprehensive systematic review of human trials investigating herbal treatments for Alzheimer's disease and dementia.

Acta neuropsychiatrica·2026
Same journal

Age-dependent increase in peripheral neuropeptide Y with no cross-sectional link to depression.

Acta neuropsychiatrica·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K

Interferon, tryptophan and depression.

D Fekkes1, A R Van Gool1

  • 11Department of Psychiatry, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands.

Acta Neuropsychiatrica
|March 18, 2016
PubMed
Summary
This summary is machine-generated.

Interferon-alpha (IFN-α) treatment can cause depression by altering brain serotonin levels. This suggests inflammation plays a role in mood disorders, offering a new research model for depression.

More Related Videos

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
10:38

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

Published on: May 9, 2020

3.8K
Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol
08:33

Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol

Published on: September 21, 2021

3.7K

Related Experiment Videos

Last Updated: Mar 24, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K
Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
10:38

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

Published on: May 9, 2020

3.8K
Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol
08:33

Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol

Published on: September 21, 2021

3.7K

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Depression frequently co-occurs with inflammatory diseases, implicating brain inflammation in mood disorders.
  • Cytokine treatments, like interferon-alpha (IFN-α), can cause neuropsychiatric side effects in patients.
  • Understanding IFN-α-induced depression may illuminate general depression pathophysiology.

Purpose of the Study:

  • To review evidence linking interferon-alpha (IFN-α) treatment, neuropsychiatric effects, and changes in immunological and serotonergic parameters.
  • To discuss the utility of IFN-α-induced depression as a model for studying general depressive disorders.

Main Methods:

  • Literature review focusing on the interplay between tryptophan, serotonin, cytokines, and depression in patients treated with interferon.
  • Analysis of existing studies on the effects of IFN-α immunotherapy on immunological and serotonergic systems.

Main Results:

  • IFN-α immunotherapy impacts immunological and serotonergic parameters, often inducing depressive symptoms.
  • Depressive symptoms during cytokine therapy appear secondary to cytokine induction, potentially via reduced brain tryptophan availability and decreased serotonin activity.
  • Altered tryptophan and serotonin metabolism may contribute to the pathophysiology of IFN-α-induced depression.

Conclusions:

  • IFN-α-induced depression highlights the potential role of immunological and serotonergic factors in general depressive disorders.
  • Further research is needed to document the specific symptomatology of IFN-α-induced depressive states.
  • Studying IFN-α side effects offers a promising avenue for understanding the biological underpinnings of depression.